Paper34201271
Synergistic Activity of New Diclofenac and Essential Oils Combinations against Different Candida spp.
Rosato A and 9 others. Antibiotics (Basel), 2021. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Synergistic Activity of New Diclofenac and Essential Oils Combinations against Different Candida spp. Papers, record 34201271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34201271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic Activity of New Diclofenac and Essential Oils Combinations against Different Candida spp.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14982754 | Combination antifungal therapy. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14982754 | PubMed |
| 2 | 16418522 | Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. | Clin Microbiol Rev | 2006 | https://conductscience.org/library/papers/16418522 | PubMed |
| 3 | 31399349 | Insights on the anticandidal activity of non-antifungal drugs. | J Mycol Med | 2019 | https://conductscience.org/library/papers/31399349 | PubMed |
| 4 | 21321363 | Chemical composition and antifungal activity of the essential oils of Lavandula viridis L'Her. | J Med Microbiol | 2011 | https://conductscience.org/library/papers/21321363 | PubMed |
| 5 | 32798221 | Invasive Candidiasis Species Distribution and Trends, United States, 2009-2017. | J Infect Dis | 2021 | https://conductscience.org/library/papers/32798221 | PubMed |
| 6 | 30067803 | Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials. | PLoS One | 2018 | https://conductscience.org/library/papers/30067803 | PubMed |
| 7 | 32131427 | Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32131427 | PubMed |
| 8 | 14062605 | A GENERALIZATION OF THE RETENTION INDEX SYSTEM INCLUDING LINEAR TEMPERATURE PROGRAMMED GAS-LIQUID PARTITION CHROMATOGRAPHY. | J Chromatogr | 1963 | https://conductscience.org/library/papers/14062605 | PubMed |
| 9 | 32078635 | Fungal diseases as neglected pathogens: A wake-up call to public health officials. | PLoS Negl Trop Dis | 2020 | https://conductscience.org/library/papers/32078635 | PubMed |
| 10 | 31470602 | Evaluation of the Antifungal Activity of Mentha x piperita (Lamiaceae) of Pancalieri (Turin, Italy) Essential Oil and Its Synergistic Interaction with Azoles. | Molecules | 2019 | https://conductscience.org/library/papers/31470602 | PubMed |
| 11 | 29099084 | Essential Oils and Antifungal Activity. | Pharmaceuticals (Basel) | 2017 | https://conductscience.org/library/papers/29099084 | PubMed |
| 12 | 26677456 | Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014. | Open Forum Infect Dis | 2015 | https://conductscience.org/library/papers/26677456 | PubMed |
| 13 | 15964727 | Medicinal plants and antimicrobial activity. | J Ethnopharmacol | 2005 | https://conductscience.org/library/papers/15964727 | PubMed |
| 14 | 26833243 | In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp. | Bioorg Med Chem | 2016 | https://conductscience.org/library/papers/26833243 | PubMed |
| 15 | 17303397 | Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. | Phytomedicine | 2007 | https://conductscience.org/library/papers/17303397 | PubMed |
| 16 | 23726352 | Comparative analysis of mass spectral matching-based compound identification in gas chromatography-mass spectrometry. | J Chromatogr A | 2013 | https://conductscience.org/library/papers/23726352 | PubMed |
| 17 | 30015451 | Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods. | Pol J Microbiol | 2018 | https://conductscience.org/library/papers/30015451 | PubMed |
| 18 | 32546021 | Diclofenac exhibits synergism with azoles against planktonic cells and biofilms of Candida tropicalis. | Biofouling | 2020 | https://conductscience.org/library/papers/32546021 | PubMed |
| 19 | 27866353 | Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms. | Folia Microbiol (Praha) | 2017 | https://conductscience.org/library/papers/27866353 | PubMed |
| 20 | 31619024 | Essential Oils and Their Natural Active Compounds Presenting Antifungal Properties. | Molecules | 2019 | https://conductscience.org/library/papers/31619024 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42450264 | Combining Diclofenac and Cannabidiol to Enhance the Antibacterial Capacity of Nonantibiotic Drugs Through Potentiation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450264 | PubMed |
| 41155175 | Beyond Antibiotics: Repurposing Non-Antibiotic Drugs as Novel Antibacterial Agents to Combat Resistance. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155175 | PubMed |
| 39768336 | In Vitro Evaluation of the Antifungal Properties of Bixa orellana L. Essential Oil from the Ecuadorian Amazon Against Candida albicans (ATCC 10231). | Life (Basel) | 2024 | https://conductscience.org/library/papers/39768336 | PubMed |
| 39338275 | Exploring the Antibiofilm Effect of Sertraline in Synergy with Cinnamomum verum Essential Oil to Counteract Candida Species. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39338275 | PubMed |
| 38947372 | Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/38947372 | PubMed |
| 38473787 | A Combination of β-Aescin and Newly Synthesized Alkylamidobetaines as Modern Components Eradicating the Biofilms of Multidrug-Resistant Clinical Strains of Candida glabrata. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473787 | PubMed |
| 38136707 | Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/38136707 | PubMed |
| 36770842 | Lavandula angustifolia Essential Oils as Effective Enhancers of Fluconazole Antifungal Activity against Candida albicans. | Molecules | 2023 | https://conductscience.org/library/papers/36770842 | PubMed |
| 36421261 | Synergistic Action of Cinnamomum verum Essential Oil with Sertraline. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36421261 | PubMed |
| 35740222 | Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35740222 | PubMed |
| 35332625 | Meta-analysis of the antifungal activities of three essential oils as alternative therapies in dermatophytosis infections. | J Appl Microbiol | 2022 | https://conductscience.org/library/papers/35332625 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34201271
GET https://conductscience.org/api/papers/v1/34201271/references?page=2